Researchers discover 'bad' cholesterol contributes to cancer spread in the body

May 7, 2014 by Rachel Gleeson

(Medical Xpress)—In a world-first, University of Sydney researchers have discovered one of the main reasons behind why cancer spreads throughout the body - the help of 'bad' cholesterol.

Published in top international journal, Cell Reports, the research found 'bad' (Low Density Lipoprotein, or LDL) regulates the machinery that controls cell migration, a major finding in the search to explain why cancer spreads throughout the body.

Paper senior author, Associate Professor Thomas Grewal from the University's Faculty of Pharmacy, said the research had important implications for cancer research.

"One of the things that makes cancer so difficult to treat is the fact that it can spread around the body," he said.

"Most of the cells in our bodies stick to neighbouring cells through the help of 'Velcro-like' molecules on their surface known as integrins. Unfortunately, integrins also help that have broken away from a cancerous tumour to take root elsewhere in the body.

"Our study identified that 'bad' (LDL) cholesterol controls the trafficking of tiny vessels which also contain these integrins, and this has huge effects on the ability of cancer cells to move and spread throughout the body.

"Our research found that having high amounts of 'bad' cholesterol seem to help the integrins in cancer cells to move and spread.

"In contrast, we found that high levels of 'good' (HDL) cholesterol keeps integrins inside cells and may therefore protect against cancer cell spread."

Researchers have extensively examined how integrins can move to the inside of cells. Most interestingly, out of several novel therapeutic opportunities, cholesterol, one of the major lipids in our body, is needed to keep integrins on the cell surface of cancer cells.

However, up to now it was unclear where this cholesterol was coming from and how one could manipulate this to treat cancer.

"Our findings contribute to the debate that may be associated with cancer incidence," Associate Professor Grewal said.

"In fact, malignant cancer cells are known to take up increased amounts of 'bad' LDL cholesterol.

"Our findings advance the theory that knowing how to manipulate and lower 'bad' cholesterol could significantly help to reduce the ability of cancer cells to spread."

Associate Professor Grewal has been collaborating with Professor Carlos Enrich from the University of Barcelona (Faculty of Medicine) in Spain for 15 years on the link between cancer and cholesterol.

About cancer: In cancer, turn into cancer cells and can grow uncontrolled and form lumps called tumours. If left untreated, cancer cells can break away from the tumour and are carried to normal tissues nearby or other parts of the body. The ability of cancer cells to spread is life threatening because they can start to grow into new tumours.

Tumours from cancers that have spread are called secondary cancers or metastases. Cancer metastasis is one of the major issues that makes cancer so difficult and researchers have long recognised that a better understanding of cancer cell spread can provide opportunities to improve cancer treatment.

Most of the cells in our bodies stick to their neighbours through the help of 'Velcro-like' molecules on their surface known as integrins. But integrins also help cancer cells that have broken away from a tumour to settle elsewhere in the body.

Knowing how to block integrins to stop cancer cells from moving can help to reduce cancer cell spread. Indeed, several pharmacological inhibitors for integrins have been developed, but these inhibitors still have limitations for clinical use.

Reducing the number of integrins at the cell surface stops cancer cell from migrating and invading other tissues and is one of the exciting therapeutic strategies investigated worldwide.

Explore further: Researchers discover protein that may control the spread of cancer

More information: "Cholesterol Regulates Syntaxin 6 Trafficking at trans-Golgi Network Endosomal Boundaries." Meritxell Reverter, et al. Cell Reports. Accepted: March 17, 2014; Published Online: April 17, 2014DOI:

Related Stories

Researchers discover protein that may control the spread of cancer

February 26, 2013
Researchers at the University of Hawai'i Cancer Center have uncovered a novel mechanism that may lead to more selective ways to stop cancer cells from spreading. Associate Professor Joe W. Ramos PhD, a cancer biologist at ...

Cholesterol unlocks clues to prostate cancer spread

April 17, 2014
(Medical Xpress)—The findings could help explain why taking statins – commonly used cholesterol-lowering drugs – is thought to slow the progress of the disease in some cases.

Study identifies path to safer drugs for heart disease, cancer

March 23, 2014
Massachusetts General Hospital (MGH) investigators may have found a way to solve a problem that has plagued a group of drugs called ligand-mimicking integrin inhibitors, which have the potential to treat conditions ranging ...

Integrin cell adhesion receptors are risky cancer drug targets

February 11, 2014
A possible cancer treatment strategy might in fact lead to increased metastasis in some cases. This finding from a team of LACDR researchers led by Erik Danen made the cover of the February 11 edition of Science Signaling.

Cancer cells use body's wound-healing mechanism to spread

February 10, 2014
Metastasis, the spread of cancer cells from a primary tumour to different organs, is responsible for more than 90% of deaths due to cancer. Current treatments such as chemotherapy or radiotherapy are effective against primary ...

DGK-alpha helps cancer cells gain traction and mobilize

January 23, 2012
Metastasizing cancer cells often express integrins that provide better traction. A new study in The Journal of Cell Biology reveals how a lipid-converting enzyme helps the cells mobilize these integrins.

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet May 07, 2014
IF there were any validity to the hypothesis that elevated LDL associates with increased cancer incidence, it could relatively easily be shown via comparison of cancer vs. non-cancer populations. There isn't any such correlation.
not rated yet May 07, 2014
Do a scholar search on cholesterol and cancer. The literature is replete with studies correlating LOW cholesterol with increased incidences of cancer. I found no scholarly articles suggesting that anyone has found actual increases in human cancers with increases in serum lipid levels.
not rated yet May 10, 2014
How about this based on a few seconds of hypothesizing and a quick check for any corroborating evidence for said impromptu hypothesis: excessive sugar/carbohydrate causes glycosylation and opens the door to the increased mobility suggested in the article? suggested analogous material below :

"These results show that N-glycan processing is essential for the function and expression of integrins in human colorectal cancer cells. An altered glycosylation of these adhesion receptors may contribute to a more invasive or metastatic phenotype in colorectal cancer."

So yet again, the sugar/carb may be implicated in driving a dysfunctional nature of LDL, AGE's, glycation damage, etc etc etc; but the researchers seem to want to blame the LDL itself, wonder why? Because that can be modified with drugs, even if LDL not truly causal in and of itself? for more in general:


Best Regards
not rated yet May 10, 2014
lazy Saturday morning here...more inflammatory fun:

not rated yet May 10, 2014
oh, and well said robbramel - the utter absence of indication that higher cholesterol links to cancer mortality, in fact the evidence for a persistent INVERSE correlation, should help these researchers focus their efforts appropriately....below is a tip-of-the-iceberg glance at this area:


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.